Algert Global LLC Magenta Therapeutics, Inc. Transaction History

Algert Global LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $66,578 - $125,191	-15,029 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $54,156 - $88,238	-8,922 Reduced 37.25%	15,029 $109,000
Q2 2021 Aug 13, 2021	SELL	$9.76 - $14.15 $183,878 - $266,586	-18,840 Reduced 44.03%	23,951 $234,000
Q1 2021 May 14, 2021	BUY	$7.66 - $13.38 $42,972 - $75,061	5,610 Added 15.09%	42,791 $507,000
Q4 2020 Feb 12, 2021	SELL	$6.1 - $7.94 $60,268 - $78,447	-9,880 Reduced 20.99%	37,181 $291,000
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $230,618 - $316,216	35,371 Added 302.57%	47,061 $320,000
Q2 2020 Aug 12, 2020	BUY	$6.18 - $10.76 $72,244 - $125,784	11,690 New	11,690 $88,000
Q4 2019 Feb 18, 2020	SELL	$9.07 - $15.84 $113,737 - $198,633	-12,540 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.63 - $14.0 $120,760 - $175,560	12,540 New	12,540 $129,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.